forest_plot
TL3 Evidence synthesis · Utrecht, NL
Systematic reviews and meta-analysis. Heterogeneity is information, not an inconvenience.
Joined 13 December 2024 · last posted 1d · groups: journal-club, wiki-editors
141 posts, newest first. Showing up to 150.
-
Aggregate verification data across the directory, with caveats Replied, post #73 · Sourcing › Independent verification · 26 Jul 2026 · 5 likes I read post #69 twice before replying, because I had assumed the opposite. An update on my earlier aggregate verification data post: the pattern held for another six…
-
Second pass at: Cost versus information: making the trade-off explicitly Replied, post #27 · Analytics › Home & field testing · 25 Jul 2026 · 0 likes Documenting home checks with dates and lots makes them accumulate into something. Undocumented ones evaporate and get remembered selectively. A partial answer, offered…
-
What a reversed-phase purity number actually is Replied, post #91 · Analytics › HPLC & UHPLC · 25 Jul 2026 · 5 likes Practical experience of reversed-phase purity number, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what…
-
Asking a follow-up: new topic or new reply? Replied, post #70 · Start Here › How to Ask · 24 Jul 2026 · 5 likes I had written a reply contradicting post #68 and deleted it. Here is what survived. Asking a follow-up came up in a thread eighteen months ago and was answered well. I…
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #85 · Analytics › Home & field testing · 23 Jul 2026 · 14 likes Understood, and I withdraw the assumption I opened with.
-
What to bring: records that a clinician can actually use Replied, post #11 · Clinical › Prescriber conversations · 21 Jul 2026 · 8 likes Where you have a specific worry, name it. "I am worried about X" is more useful to a clinician than a series of questions circling X. This is the sort of thing that…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #97 · Access › International · 21 Jul 2026 · 20 likes Marking my place. If it changes for me I will come back and say so.
-
Restarting after a long gap: what the labelling implies Replied, post #31 · Practice › Dosing & titration · 18 Jul 2026 · 22 likes On post #27 — agreed on the reasoning, with one qualification. Titrating on symptoms rather than on the calendar is what most people here actually do. It is defensible,…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #31 · Sourcing › Regulatory · 17 Jul 2026 · 20 likes My experience of compounding permissions contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is…
-
How much context is too much context in a first post? Replied, post #30 · Start Here › How to Ask · 7 Jul 2026 · 8 likes Disagreeing with an answer you got: cite what you disagree with, say what contradicts it, and ask which one holds. Do not open with "I think you are wrong". Lead with…
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #64 · Analytics › Home & field testing · 2 Jul 2026 · 3 likes Answering the question post #62 raises rather than the one it answers. The tare problem is the catch with weighing: vial-to-vial glass mass varies, so the useful…
-
Selection into a registry and what it does to the estimate — a second dataset Replied, post #4 · Evidence › Study critique · 30 Jun 2026 · 0 likes Worth separating two things that post #2 runs together. I have no financial interest in anything named in this thread and I want to say so before I comment on…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #74 · Analytics › Home & field testing · 30 Jun 2026 · 0 likes Narrowing post #72, because the general version has more than one answer. False positives and false negatives: no test has 100% sensitivity and 100% specificity. A…
-
Fixed versus detachable needles: the trade-offs — does this still hold? Replied, post #9 · Devices › Syringes & needles · 28 Jun 2026 · 24 likes Fixed versus detachable needles: insulin syringes usually have fixed needles (no dead volume loss to the hub). Luer-lock syringes use detachable needles (more dead…
-
MS/MS sequence confirmation: what it costs and when it is worth it — what changed since Replied, post #39 · Analytics › Mass spectrometry · 18 Jun 2026 · 5 likes Worth separating two things that post #35 runs together. Calibration state at the time of the run determines whether the ppm figure means anything. A report that states…
-
How much of the diluent volume the powder itself displaces Replied, post #2 · Practice › Reconstitution · 17 Jun 2026 · 0 likes Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on injection. Isotonic solutions (close to blood osmolarity) are less…
-
Pages past their review date, listed — does this still hold? Replied, post #11 · Meta › Wiki maintenance · 13 Jun 2026 · 26 likes Post #7 describes the usual case. This is about the unusual one. Volunteering for the review on this one. I use it monthly, I have a list of three things that have aged…
-
Research-use-only status: what it means legally and practically Replied, post #57 · Compounds › Other compounds · 12 Jun 2026 · 26 likes Picking up post #54: that is the part I would want checked first. An update on my earlier research-use-only status post: the pattern held for another six weeks and then…
-
Transporting a vial for a weekend away — a second dataset Replied, post #73 · Practice › Storage & stability · 5 Jun 2026 · 18 likes Transporting a vial looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
-
Joined after a search result and stayed Replied, post #5 · Lounge › Introductions · 23 May 2026 · 1 like No judgment: people come to this community from all backgrounds and with all motivations. Introductions are for getting to know each other, not for evaluation. That…
-
Citation sweep results: how many references did not say what was claimed Replied, post #97 · Meta › Wiki maintenance · 18 May 2026 · 4 likes I had written a reply contradicting post #95 and deleted it. Here is what survived. Two questions I would want answered before drawing anything from the citation sweep…
-
Follow-up: Search filters: what is missing Replied, post #104 · Meta › Site feedback · 17 May 2026 · 4 likes Community norms: if you think a norm has drifted or is not being followed consistently, raising it here can prompt discussion and realignment. The disagreement above is…
-
Conditions that change the calculus rather than forbidding it Replied, post #15 · Safety › Contraindications · 15 May 2026 · 15 likes Confirming post #14 from a second method, which matters more than confirming it from a second person. Conditions looks different depending on whether you are reading…
-
Revisiting: The arithmetic of an intermediate dose between two label steps Replied, post #13 · Practice › Dosing & titration · 15 May 2026 · 1 like That is a fair summary of where the discussion has got to.
-
Two scans six weeks apart on different machines: a cautionary tale Replied, post #18 · Outcomes › Body composition · 14 May 2026 · 19 likes Bone mineral density changes with substantial weight loss are measurable and slow, and are one of the better reasons to have a baseline scan. Take the reasoning and…
-
Journal club: LEADER as the historical anchor Replied, post #68 · Evidence › Journal club · 2 May 2026 · 4 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
A checklist for reading a certificate in under two minutes Replied, post #8 · Analytics › COA interpretation · 20 Apr 2026 · 0 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #82 · Research Methods › Statistics · 19 Apr 2026 · 6 likes Offering a way to settle Measurement error in home scales rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the…
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #57 · Research Methods › N-of-1 designs · 17 Apr 2026 · 6 likes I had written a reply contradicting post #53 and deleted it. Here is what survived. Order effects matter. If you always try A before B, you cannot separate the…
-
What changed in 2026, by region — does this still hold? Replied, post #3 · marked as the solution · Access › International · 15 Apr 2026 · 18 likes Nothing here is legal advice, and in this subcategory that caveat is doing real work rather than sitting decoratively at the end.
-
Prescription requirements and telehealth models — a second dataset Replied, post #4 · Sourcing › Regulatory · 15 Apr 2026 · 0 likes Where a claim about legality is made here, the useful follow-up is which instrument it rests on. Most such claims turn out to rest on a forum post.
-
The "under review" status pill and when a moderator applies it Replied, post #75 · Evidence › Preprints · 15 Apr 2026 · 19 likes Where I part company with post #71, and it is a narrow parting. Unrefereed work is not worthless. A great deal of it survives review substantially unchanged. It is also…
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #5 · Analytics › Home & field testing · 2 Apr 2026 · 8 likes Post #3 and I disagree about the size of the effect, not about the direction. The reason Reflectance and photometric devices is hard to answer is that the obvious…
-
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #59 · Research Methods › N-of-1 designs · 28 Mar 2026 · 3 likes Order effects matter. If you always try A before B, you cannot separate the treatment from the sequence, and alternating is cheap. Two people can read the same figure…
-
Batch numbers that do not match the vial label Started this topic · Sourcing › Red flags · 26 Mar 2026 · 19 likes Batch numbers that do not match the vial label — setting out what I have, and where I think it stops being reliable. Structured question about turnaround and what it…
-
About the Special populations category Replied, post #4 · Clinical › Special populations · 25 Mar 2026 · 0 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #24 · Analytics › Mass spectrometry · 22 Mar 2026 · 16 likes Second this, and I would have said it less carefully.
-
Where impurities in solid-phase peptide synthesis come from Replied, post #51 · Analytics › Impurities & related substances · 18 Mar 2026 · 23 likes This follows post #50 rather than contradicting it. Incomplete deprotection leaves a protecting group attached, raising the mass substantially and usually pushing…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #11 · Analytics › Mass spectrometry · 16 Mar 2026 · 0 likes Worth separating two things that post #7 runs together. An honest declaration on Charge states: I have a prior here and it is strong enough that you should weight what…
-
[2026 update] What a purity-only report leaves out Replied, post #51 · Sourcing › Independent verification · 12 Mar 2026 · 1 like Summarising the purity-only thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it, and the rest…
-
A parcel stationary at a customs facility for nine days Replied, post #35 · Sourcing › Logistics · 5 Mar 2026 · 0 likes Customs holds: if a parcel is held at customs and you can contact customs directly, declaring your personal use and providing documentation (order, labelling) can help.…
-
The lowest dose that does anything: is that a real question? Replied, post #43 · Practice › Dosing & titration · 4 Mar 2026 · 1 like The arithmetic in post #42 is right; the assumption feeding it is the part to check. If you are stepping up mainly because the schedule says so rather than because the…
-
Coming back to: Reading a supplier's product description as a marketing document Replied, post #40 · Compounds › Other compounds · 28 Feb 2026 · 16 likes Fragment compounds — where the material is part of a larger natural protein — should be identified by sequence rather than by name, because the naming in this space is…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #11 · Compounds › Semaglutide · 27 Feb 2026 · 17 likes Renal outcomes moved this compound out of the metabolic-only conversation. FLOW reported on kidney endpoints in people with type 2 diabetes and chronic kidney disease,…
-
Fibre intake when total intake falls, and the constipation link — one year on Started this topic · Nutrition & Training › Protein & intake · 20 Feb 2026 · 0 likes Posting this under the heading it deserves: Fibre intake when total intake falls, and the constipation link — one year on Everything below is what sits behind that. An…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #95 · Practice › Dosing & titration · 20 Feb 2026 · 28 likes The maximum studied dose is a fact about the trial and not a ceiling on the molecule. It is also the last point at which anything is known, which is the reason to treat…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #24 · Sourcing › Vendor reports · 17 Feb 2026 · 1 like Coming back to post #20, because the follow-up matters more than the original answer. Structured report format: compound, lot, independent testing service, method as…
-
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #11 · Analytics › Impurities & related substances · 9 Feb 2026 · 2 likes This follows post #8 rather than contradicting it. Practical answer on rising related-substance, since the theoretical one is upthread: do the simplest check first,…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #33 · Clinical › Special populations · 5 Feb 2026 · 19 likes Post #31 describes the usual case. This is about the unusual one. Post-surgical populations, particularly after procedures affecting the gastrointestinal tract,…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #103 · Sourcing › Independent verification · 31 Jan 2026 · 0 likes Agreed on all of that, and I have nothing to add to it.
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #72 · Sourcing › Red flags · 31 Jan 2026 · 5 likes Post #68 put the caveat in the right place and I want to underline it. A supplier changing batch nomenclature is not a warning sign, and it does make historical…
-
Specification in the result column: why that is a meaningful error Replied, post #112 · Analytics › COA interpretation · 27 Jan 2026 · 0 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #22 · Sourcing › Logistics · 15 Jan 2026 · 0 likes Answering the question post #20 raises rather than the one it answers. Documentation after arrival: photograph the parcel and its contents on arrival. If something…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #54 · Access › International · 13 Jan 2026 · 0 likes Narrowing post #53, because the general version has more than one answer. Worth separating Language barriers in accessing as a question about the compound from Language…
-
Where to report an adverse event officially, by region Started this topic · Safety › Adverse events · 8 Jan 2026 · 34 likes Where to report an adverse event officially, by region Writing it up because I had to work it out twice and would rather nobody else did. Reporting an event with the…
-
How to read a forest plot, properly, from scratch Replied, post #81 · Evidence › Trials · 4 Jan 2026 · 7 likes Absolute and relative effects answer different questions. Write down the event rate in each arm and the difference between them; everything quotable is derived from…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #42 · Practice › Side effects · 27 Dec 2025 · 7 likes Tracking severity on a simple scale with dates is far more useful than describing it afterwards. Memory smooths a symptom curve into a story that fits what you…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #29 · Pharmacology › Receptor biology · 27 Dec 2025 · 0 likes Glucagon receptor agonism raises energy expenditure and promotes hepatic fat oxidation. In a triple agonist the incretin limbs offset the glycaemic consequence, which…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #56 · Sourcing › Independent verification · 26 Dec 2025 · 1 like Post #52 describes the usual case. This is about the unusual one. Adding a small correction to the interpreting a result summary above rather than a disagreement with…
-
What "verified" means on our vendor pages, stated narrowly Replied, post #9 · Sourcing › Vendor reports · 25 Dec 2025 · 21 likes Post #8 answers the question as asked. The question underneath it is different. Reports of ordinary results are more valuable than reports of remarkable ones, precisely…
-
The decimal-point error, and the habit that catches it Replied, post #80 · Practice › Reconstitution · 17 Dec 2025 · 13 likes The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common arithmetic error in this subcategory. The habit that catches it:…
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #17 · Data & Tools › Calculators · 10 Dec 2025 · 2 likes Coming back to post #15, because the follow-up matters more than the original answer. Rounding behaviour is where two tools disagree. One rounding to the nearest…
-
[2026 update] Why mass spectrometry cannot tell you about an epimer Replied, post #3 · Analytics › Mass spectrometry · 8 Dec 2025 · 0 likes Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment masses to confirm identity and detect modifications. A simple identity confirmation by…
-
Substitution between formats during a shortage Replied, post #107 · Access › Shortages · 2 Dec 2025 · 1 like Coming back to post #103, because the follow-up matters more than the original answer. Dose hold versus tapering: if a temporary shortage forces a gap, holding your…
-
How to read a forest plot, properly, from scratch Replied, post #62 · Evidence › Trials · 28 Nov 2025 · 0 likes A treatment-policy estimand asks what happens to people assigned to a strategy, including those who abandon it. A hypothetical estimand asks what would have happened…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #32 · Practice › Reconstitution · 24 Nov 2025 · 0 likes Post #28 describes the usual case. This is about the unusual one. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #88 · Start Here › How to Ask · 12 Nov 2025 · 1 like Quantities without units are the single commonest reason a question sits unanswered. "Two and a half" is not a dose, a volume or a concentration until you say which.…
-
Specification in the result column: why that is a meaningful error Replied, post #71 · Analytics › COA interpretation · 10 Nov 2025 · 13 likes Answering the question post #67 raises rather than the one it answers. A chromatogram supplied as a small image is legible for peak shape and not for baseline detail.…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #24 · Clinical › Special populations · 3 Nov 2025 · 0 likes Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist requires insulin dose reduction and close monitoring for hypoglycemia. This is…
-
About the How to Ask category Replied, post #4 · Start Here › How to Ask · 25 Oct 2025 · 21 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
-
Sleep tracking data and its considerable limitations Replied, post #79 · Wellbeing › Sleep · 24 Oct 2025 · 7 likes Narrowing post #76, because the general version has more than one answer. Sleep quality versus quantity: some people report changes to sleep duration; others report…
-
Appeal templates and why they are deliberately unemotional Replied, post #18 · Access › Insurance & coverage · 11 Oct 2025 · 4 likes An update on my earlier appeal templates post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
-
Follow-up: Subcutaneous absorption kinetics and site differences Replied, post #2 · Pharmacology › Pharmacokinetics · 8 Oct 2025 · 9 likes SNAC (the oral bioavailability enhancer): sodium N-(8-[2-hydroxybenzoyl]amino) caprylate transiently raises gastric pH and promotes absorption. Without it, oral…
-
Compounds this community declines to help with, and why Replied, post #73 · Compounds › Other compounds · 6 Oct 2025 · 0 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #75 · Lounge › Off topic · 4 Oct 2025 · 28 likes Newer drugs and mechanisms: when a new drug launches or a new mechanism is discovered, the Lounge is a place to discuss the news and speculate before hard data exists.…
-
High-resolution MS on aggregates and what it can see Replied, post #84 · Analytics › Mass spectrometry · 4 Oct 2025 · 0 likes Resolution: "high resolution" commonly means Take it as a starting point and not as a specification.
-
Reconciling a label claim with a content assay Replied, post #3 · Analytics › COA interpretation · 28 Sep 2025 · 12 likes Water content (residual moisture) matters: lyophilised peptide is not dry. A few percent water is normal. The difference between a TFA salt and an acetate salt can be…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #59 · Evidence › Study critique · 14 Sep 2025 · 2 likes Building consensus on which criticisms matter: if everyone agrees that the sample size is small but only you think that affects the conclusion, maybe your criticism is…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #144 · Data & Tools › Datasets · 11 Sep 2025 · 19 likes Publishing the raw records alongside the summary is what makes a dataset checkable. A summary alone asks for trust that nobody has earned. I am not the right person to…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #22 · Lounge › Off topic · 6 Sep 2025 · 1 like Something I have wondered without ever asking: is there a good reason the vocabulary in this field is so inconsistent between suppliers? Half the disagreements here…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #33 · Practice › Administration · 25 Aug 2025 · 5 likes I would keep pinch and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and merging them is why the…
-
Follow-up: Why appetite effects are mostly central Replied, post #19 · Pharmacology › Receptor biology · 16 Aug 2025 · 0 likes Where the appetite effects discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same sentence…
-
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #51 · Evidence › Journal club · 11 Aug 2025 · 19 likes Building on post #49 rather than restating it. An hour is enough for one paper read properly and not enough for two read partly. The temptation is always to add the…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #68 · Evidence › Trials · 4 Aug 2025 · 18 likes I have no financial interest in anything named in this thread and I want to say so before I comment on Sample size calculations, because it is the sort of subject where…
-
What this community means by "a source", in practical terms Replied, post #56 · Start Here › Welcome · 2 Aug 2025 · 19 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #50 · Clinical › Special populations · 30 Jul 2025 · 31 likes Reading back through, this was answered upthread and I missed it. My fault.
-
Temperature loggers worth the money — the long version Replied, post #17 · Devices › Cold chain · 28 Jul 2025 · 2 likes Post #15 and I disagree about the size of the effect, not about the direction. On Temperature loggers worth the money the community has more anecdote than the…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #59 · Access › Insurance & coverage · 28 Jul 2025 · 29 likes Coming back to post #57, because the follow-up matters more than the original answer. Reimbursement changes: a compound covered one year might not be the next. A…
-
A field-by-field walk through a certificate of analysis Replied, post #38 · Analytics › COA interpretation · 15 Jul 2025 · 0 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
-
A friction point in the promotion workflow Started this topic · Meta › Site feedback · 14 Jul 2025 · 35 likes A friction point in the promotion workflow — setting out what I have, and where I think it stops being reliable. Asking about friction point directly, because I have…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #24 · Sourcing › Vendor reports · 12 Jul 2025 · 0 likes On post #22 — agreed on the reasoning, with one qualification. Do not adjust a reported figure. Post what the laboratory said and put your interpretation in a separate…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #28 · Practice › Reconstitution · 4 Jul 2025 · 0 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
Criticising the method without criticising the authors — one year on Replied, post #9 · Evidence › Study critique · 1 Jul 2025 · 23 likes Defending a design that is being criticised unfairly is as useful as criticising one that deserves it, and it happens far less often.
-
What this community means by "a source", in practical terms Replied, post #12 · Start Here › Welcome · 22 Jun 2025 · 28 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #67 · Compounds › Retatrutide · 19 Jun 2025 · 20 likes Narrowing post #66, because the general version has more than one answer. Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it…
-
Coming back to: Getting a referral rather than a refusal Replied, post #75 · Clinical › Prescriber conversations · 16 Jun 2025 · 0 likes A question phrased as "what would you want to see before considering X" is answerable and is not a request for X. Not the answer, but possibly the question that gets…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #67 · Practice › Reconstitution · 10 Jun 2025 · 0 likes Where I part company with post #63, and it is a narrow parting. A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #37 · Evidence › Trials · 8 Jun 2025 · 7 likes Two people in this thread mean different things by Sample size calculations and are disagreeing about the definition while believing they are disagreeing about the…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #35 · Compounds › Cagrilintide & amylin analogues · 7 Jun 2025 · 10 likes That is clearer than the version I had in my head. Thank you.
-
Coming back to: Getting a referral rather than a refusal Replied, post #22 · Clinical › Prescriber conversations · 1 Jun 2025 · 5 likes A question phrased as "what would you want to see before considering X" is answerable and is not a request for X. Not disagreeing with anyone above, just adding the bit…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #97 · Practice › Interactions · 23 May 2025 · 0 likes I had written a reply contradicting post #95 and deleted it. Here is what survived. SGLT2 inhibitors: frequently co-administered and relevant to renal and…
-
Payment mechanics and the recovery options that do not exist — what changed since Replied, post #9 · Sourcing › Payments · 14 May 2025 · 1 like I will take the caveat as seriously as the claim, which is the point of putting it there.
-
A ten-fold dose error caught before injection Replied, post #32 · Devices › Syringes & needles · 10 May 2025 · 20 likes Marking my uncertainty on ten-fold dose error caught explicitly. I am confident about the direction, much less confident about the size, and not confident at all that…
-
Promotion criteria, and the one that stops most nominations — the long version Started this topic · Documentation › Doc review · 7 May 2025 · 21 likes On the subject in the title: Promotion criteria, and the one that stops most nominations — the long version Working notes rather than a conclusion. A narrow question…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #46 · Wellbeing › Mental health · 6 May 2025 · 0 likes Before the thread moves on from history of disordered eating — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted…
-
Water content on a certificate and why it changes the arithmetic Replied, post #10 · Analytics › COA interpretation · 1 May 2025 · 0 likes Adding thanks rather than a view. I do not have a view worth the space.
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #36 · Compounds › Cagrilintide & amylin analogues · 29 Apr 2025 · 0 likes The practical version of cagrisema phase 2 paper is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #38 · Compounds › Retatrutide · 16 Apr 2025 · 2 likes Building on post #35 rather than restating it. Adding a null result on Triple agonism. I looked, carefully, and found nothing, and null results deserve posting…
-
Certificates issued by the seller versus by a laboratory Replied, post #41 · Analytics › COA interpretation · 12 Apr 2025 · 0 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
-
Follow-up: Journal club: the retatrutide phase 2 obesity paper Replied, post #18 · Evidence › Journal club · 3 Apr 2025 · 30 likes Confirming post #15 from a second method, which matters more than confirming it from a second person. Bringing the previous paper on the same question makes the session…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #43 · Compounds › Tirzepatide · 20 Mar 2025 · 0 likes Worth separating two things that post #42 runs together. I disagree with the framing of tirzepatide in type 2 diabetes above, and I think it is a substantive…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #132 · Compounds › Semaglutide · 19 Mar 2025 · 33 likes The failure mode on Semaglutide half-life is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to…
-
Coming back to: An 18-month record including the parts that went badly Replied, post #25 · Outcomes › Progress reports · 9 Mar 2025 · 0 likes On 18-month record I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is how…
-
Oxidation and deamidation mass shifts, tabulated Replied, post #66 · Analytics › Mass spectrometry · 5 Mar 2025 · 26 likes Monoisotopic and average mass are different numbers and both appear on documents. At this molecular weight the difference is a few daltons, which is more than the…
-
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #11 · Evidence › Journal club · 25 Feb 2025 · 0 likes Worth separating two things that post #9 runs together. SURMOUNT-OSA sits at the boundary between what this community can usefully discuss and what it cannot, and I…
-
Coming back to: Column chemistry choices for a 40-residue peptide Replied, post #2 · Analytics › HPLC & UHPLC · 24 Feb 2025 · 4 likes Coming back to the opening post, because the follow-up matters more than the original answer. Detection wavelength: 214 nm detects the peptide bond and is relatively…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #49 · Sourcing › Red flags · 7 Feb 2025 · 4 likes A stock listing that never changes and a lead time that never varies are both worth noticing. Real operations have variation in them.
-
Cost per milligram, computed honestly across formats — the long version Replied, post #4 · Access › Pricing · 5 Feb 2025 · 6 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #9 · Clinical › Comorbidities · 5 Feb 2025 · 6 likes Post #6 is the version of this I will quote in future. One addition. Renal function affects clearance for some compounds in this class and not others. The published…
-
Second pass at: Regression to the mean in progress reports Replied, post #40 · Research Methods › Statistics · 31 Jan 2025 · 7 likes Answering the question post #38 raises rather than the one it answers. Regression to the mean: if you select people with extreme values (very high or very low), their…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #86 · Analytics › COA interpretation · 30 Jan 2025 · 6 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #8 · Practice › Reconstitution · 27 Jan 2025 · 24 likes Adding a small correction to the 5 mg vial summary above rather than a disagreement with it. The substance holds; one of the figures is out by a factor that matters.
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #26 · Compounds › Semaglutide · 13 Jan 2025 · 5 likes Post #22 describes the usual case. This is about the unusual one. Source for the published dose-response for semaglutide figure, since it was asked for. It is in the…
-
Triple agonism: additive, synergistic, or neither? Replied, post #10 · Compounds › Retatrutide · 13 Jan 2025 · 12 likes The failure mode on triple agonism is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to get wrong.
-
Anxiety in the first weeks: drug, situation, or both Replied, post #36 · Wellbeing › Mental health · 9 Jan 2025 · 0 likes Post #33 answers the question as asked. The question underneath it is different. Two things can be true about anxiety at once: the mechanism is plausible and the…
-
Transit times by route, from a logged dataset — the long version Replied, post #47 · Sourcing › Logistics · 8 Jan 2025 · 2 likes What I would tell a new member reading about Transit times for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.
-
Washout with a one-week half-life: the arithmetic Replied, post #40 · Research Methods › N-of-1 designs · 30 Nov 2024 · 5 likes I read post #36 twice before replying, because I had assumed the opposite. Summarising the washout thread so far, since it is long and the answer is buried: the first…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #98 · Practice › Dosing & titration · 5 Nov 2024 · 0 likes That matches what I have seen, for whatever a single anecdote is worth.
-
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #27 · Wellbeing › Mental health · 12 Oct 2024 · 30 likes Worth separating two things that post #23 runs together. If someone has run Food noise properly I would rather read that than my own reconstruction of it. Posting mine…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #30 · Compounds › Tirzepatide · 8 Oct 2024 · 20 likes On purity: the trailing-edge features people report on tirzepatide chromatograms are frequently deamidation products, which elute close to the main peak and are easy to…
-
A revision dispute resolved on the topic rather than in the history — a second dataset Started this topic · Meta › Wiki maintenance · 1 Oct 2024 · 57 likes On the subject in the title: A revision dispute resolved on the topic rather than in the history — a second dataset Working notes rather than a conclusion. Posting a…
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #37 · Devices › Syringes & needles · 19 Sep 2024 · 4 likes Dead volume: residual liquid in the hub and needle after withdrawal. Typical residual is 0.01 to 0.02 mL for an insulin syringe with a fixed needle. Accounting for it…
-
High-resolution MS on aggregates and what it can see — one year on Replied, post #12 · Analytics › Mass spectrometry · 11 Aug 2024 · 6 likes I read post #9 twice before replying, because I had assumed the opposite. Deamidation adds approximately one dalton and produces a species that frequently elutes very…
-
Follow-up: Oral contraceptives and delayed emptying: what the data shows Replied, post #8 · Practice › Interactions · 30 Jul 2024 · 9 likes Alcohol is not contraindicated in the labelling and it does irritate a stomach that is already emptying slowly. There is no published interaction study, and the…
-
Reporting a discrepancy without making an allegation Replied, post #4 · Sourcing › Vendor reports · 25 Jul 2024 · 11 likes Agreed, and I will stop repeating the version of this I had been repeating.
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #41 · Compounds › Retatrutide · 18 Jul 2024 · 10 likes Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not established is whether the tolerability profile differs from…
-
Journal club: FLOW and the renal composite, component by component Replied, post #63 · Evidence › Journal club · 15 Jul 2024 · 4 likes The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions.
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #113 · Practice › Dosing & titration · 10 Jul 2024 · 0 likes Adding a data point of agreement rather than a data point.
-
Two sessions a week versus four: what the evidence supports — a second dataset Replied, post #27 · Nutrition & Training › Resistance training · 7 Jul 2024 · 0 likes The reports here that state the programme, the load and the timeframe are useful. The ones that state an outcome are not.
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #11 · Clinical › Prescriber conversations · 25 Jun 2024 · 7 likes Where I part company with post #9, and it is a narrow parting. Questions about dose: asking "how will we determine whether this dose is working for me" gets at the…
-
Assessing a warm arrival: the decision process — one year on Replied, post #57 · Sourcing › Logistics · 30 May 2024 · 22 likes The most useful logistics record is boring: order date, dispatch date, arrival date, condition on arrival. Four fields, and they answer most questions here.